Protalix BioTherapeutics
PLX
#9051
Rank
ยฃ0.14 B
Marketcap
ยฃ1.82
Share price
3.33%
Change (1 day)
52.08%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2026 (TTM): ยฃ0.16

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is ยฃ0.15. In 2025 the company made an earnings per share (EPS) of -ยฃ0.05885 a decrease over its 2024 EPS that were of ยฃ0.02943.

EPS history for Protalix BioTherapeutics from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ0.16-367.26%
2025-ยฃ0.05885-300%
2024ยฃ0.02943-66.67%
2023ยฃ0.08828-138.71%
2022-ยฃ0.23-50%
2021-ยฃ0.46181.82%
2020-ยฃ0.16-82.11%
2019-ยฃ0.90-31.67%
2018-ยฃ1.32-72.31%
2017-ยฃ4.78124.14%
2016-ยฃ2.13-147.54%
2015ยฃ4.49-290.63%
2014-ยฃ2.356.67%
2013-ยฃ2.21130.77%
2012-ยฃ0.96-69.77%
2011-ยฃ3.1619.44%
2010-ยฃ2.65-12.2%
2009-ยฃ3.0236.67%
2008-ยฃ2.21-37.5%
2007-ยฃ3.5350%
2006-ยฃ2.353.23%
2005-ยฃ2.28138.46%
2004-ยฃ0.96-74%
2003-ยฃ3.68-0%
2002-ยฃ3.68-50%
2001-ยฃ7.36233.33%
2000-ยฃ2.21-84.21%
1999-ยฃ13.98-24%
1998-ยฃ18.39-600%
1997ยฃ3.68-16.67%
1996ยฃ4.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ0.96 523.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ4.94 3,095.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-ยฃ0.08092-152.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.01 552.38%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel